Sclerosing panniculitis is associated with pulmonary hypertension in systemic sclerosis

British Journal of Dermatology

Volumn 153, Issue 3, 2005, Pages 579-583

  Jinnin, M ^a   Ihn, H ^a   Asano, Y ^a   Yamane, K ^a   Yazawa, N ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Echocardiogram; Pulmonary embolism; Pulmonary hypertension; Sclerosing panniculitis; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG INFARCTION; MAJOR CLINICAL STUDY; MALE; PANNICULITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLEROSING PANNICULITIS; SYSTEMIC SCLEROSIS; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; MALE; MIDDLE AGED; PANNICULITIS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; STATISTICS, NONPARAMETRIC;

EID: 24344508240     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06680.x     Document Type: Article

References (23)

1. Jorizzo JL, White WL, Zanolli MD et al. Sclerosing panniculitis. A clinicopathologic assessment. Arch Dermatol 1991; 127:554-8.
2. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993; 28:623-7.
3. Demitsu T, Okada O, Yoneda K, Manabe M. Lipodermatosclerosis-report of three cases and review of the literature. Dermatology 1999; 199:271-3.
4. Alegre VA, Winkelmann RK, Aliaga A. Lipomembranous changes in chronic panniculitis. J Am Acad Dermatol 1988; 19:39-46.
5. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979; 22:130-40.
6. LeRoy EC. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 1992; 51:3412-9.
7. LeRoy EC, Black CM, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-6.
8. Ihn H, Sato S, Fujimoto M et al. Measurement of anticardiolipin antibodies by ELISA using β2-glycoprotein I (β2-GPI) in systemic sclerosis. Clin Exp Immunol 1998; 37:1188-92.
9. Subcommittee for Scleroderma Criteria of the ARA Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-9.
10. Yamane K, Ihn H, Asano Y et al. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford) 2000; 39:1269-71.
11. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31:196-203.
12. Stupi AM, Steen VD, Owens GR et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29:515-23.
13. Ihn H, Sato S, Tamaki T et al. Clinical evaluation of scleroderma spectrum disorders using a points system. Arch Dermatol Res 1992; 284:391-5.
14. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74:1185-90.
15. Harris EN. The Second International Anticardiolipin Standardization Workshop/The Kingston Antiphospholipid Antibody Study Group. Am J Clin Pathol 1990; 94:476-84.
16. Salerni R, Rodnan GP, Leon DF, Shaver JA. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977; 86:394-9.
17. Ungerer RG, Tashkin DP, Furst D et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983; 75:65-74.
18. Steen VD, Owens GR, Fino GJ et al. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992; 28:759-67.
19. Negi VS, Tripathy NK, Misra R, Nityanand S. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary hypertension. J Rheumatol 1998; 25:462-6.
20. Kharitonov SA, Cailes JB, Black CM et al. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997; 52:1051-5.
21. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81:1735-43.
22. Maeda M, Kachi H, Kitajima Y. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS). J Dermatol Sci 1996; 13:18-24.
23. Denton CP, Cailes JB, Phillips GD et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997; 36:239-43.